Entrada Therapeutics
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $153M
Investors
- 14
About Entrada Therapeutics
Based in Boston, US and founded in 2016 by Dehua Pei and Leo Qian, Entrada Therapeutics, Inc. is a biotechnology company that develops treatments for devastating diseases using intracellular biologics. In March 2021, Entrada Therapeutics, Inc.5 million in its IPO and got listed on NASDAQ under the ticker symbol TRDA. Entrada Therapeutics, Inc. develops and sells Endosomal Escape Vehicle (EEVTM) technology, which allows for the efficient intracellular delivery of proteins, peptides, and nucleic acids, allowing for the development of programs for intracellular target classes and the treatment of a variety of neuromuscular diseases. Entrada Therapeutics, Inc. intends to move its platform and pipeline into clinical trials.
Who invested in Entrada Therapeutics
14 investors across 2 rounds
See all investors in Entrada Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Entrada Therapeutics
Who invested in Entrada Therapeutics?
Entrada Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Entrada Therapeutics raised?
Entrada Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Entrada Therapeutics last raise money?
Entrada Therapeutics's most recent round on record is a Series B, in Mar 2021.
What does Entrada Therapeutics do?
Based in Boston, US and founded in 2016 by Dehua Pei and Leo Qian, Entrada Therapeutics, Inc.
Where is Entrada Therapeutics headquartered?
Entrada Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Entrada Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Entrada Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Entrada Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.